	Comparative evaluation of VoxelMorpand conventional deformable image registration algorithms for thoracic 4D-CT in radiotherapy. J Appl Clin Med Phys Sakai M, Nakao M, Hirashima H, Yoneyama M, Kishi N, Mizowaki T, Nakamura M. PMID: 42775600 [PubMed - indexed for MEDLINE]
	Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume. J Appl Clin Med Phys Wang Y, Xu D, Liu Y, Zhang X, Yu L. PMID: 42775580 [PubMed - indexed for MEDLINE]
	Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review. Cureus Kumar S, Mudgal SK, Varikasuvu SR, Singh D, Singh H, Mahato S, Sarangi PK, Mondal H. PMID: 42775053 [PubMed]
	Correction: Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study. Front Med (Lausanne) Frontiers Production Office. PMID: 42775016 [PubMed]
	Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer. EClinicalMedicine Hulskotte LMG, Veerman GDM, Lanser DAC, Reyners AKL, van Schaik RHN, Dingemans AC, Taxis K, Mathijssen RHJ, Jansman FGA. PMID: 42775005 [PubMed]
	Respiratory omics for early detection of COPD-to-lung cancer transition: mechanisms, biomarkers and clinical translation. Front Cell Dev Biol Liu C, Jia W, Jing S, Dong C. PMID: 42774579 [PubMed]
	Case Report: Invasive mucinous adenocarcinoma mimicking interstitial pneumonia with autoimmune features: diagnostic pitfalls and reflections. Front Immunol Tian J, Li G, Zhang H, Ma Z. PMID: 42774218 [PubMed - indexed for MEDLINE]
	Economic evaluations of next-generation sequencing for targeted therapy in non-small cell lung cancer: a systematic review. Front Public Health Dai Z, Ye W, Zhou J, Tian L. PMID: 42774169 [PubMed - indexed for MEDLINE]
	Development and validation of a machine-learning-based triage model incorporating systemic inflammatory, nutritional, coagulation, and tumor marker parameters for identifying baseline distant metastasis in lung cancer. Front Oncol Yuan H, Chen J, Liu W, Luo N, Fang X. PMID: 42774047 [PubMed]
	Psychometric Properties of the EORTC QLQ-LC29 Module for Assessing Quality of Life in Patients with Lung Cancer: An Observational Study in Antioquia, Colombia. Int J Psychol Res (Medellin) Medina-Pabón MA, Tatis-Méndez JF, Pérez-García YE, García-García HI, Koller M. PMID: 42773996 [PubMed]
	Multiomics analysis identifies RNASET2 as a potential candidate target associated with lung adenocarcinoma. J Int Med Res Shi Y, Yang J, Cai F, Huang J, Bi J, Wang K, Wang G, Kong X, Lang Y, Zhang J, Xu S, Xu H. PMID: 42773948 [PubMed - indexed for MEDLINE]
	Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non-small-cell lung cancer: a randomized, multicenter, phase II trial. Cancer Biol Med Li M, Liu C, Ran F, Lan H, Ge J, Zhao Z, Rao C, Zheng W, Tang X, Gao T, Mao Y, Cui W, Li Z, Huang D. PMID: 42773790 [PubMed - as supplied by publisher]
	Applications of artificial intelligence in dyspnoea management for patients with advanced lung cancer: a scoping review protocol. BMJ Open Zhang X, Wang L, Sun Y, Zhang W, Zheng X. PMID: 42772888 [PubMed - indexed for MEDLINE]
	Neoadjuvant QL1706 plus chemotherapy in patients with stage II-IIIB squamous non-small cell lung cancer: study protocol for a prospective, single-arm, multicentre phase II trial. BMJ Open Jin Y, Luo T, Chu J, Zeng J. PMID: 42772869 [PubMed - indexed for MEDLINE]
	Impact of CT scan-based vs. minimal follow-up on patient-reported outcomes after surgery for non-small cell lung cancer in IFCT-0302 phase III trial. J Thorac Cardiovasc Surg Eberst G, Henriques J, Thomas PA, Giroux-Leprieur E, Mercier O, Pagès PB, Ravier P, Bayle S, Valette CA, Berard H, Lagrange A, Bonnefoy P, Langlais A, Vernerey D, Anota A, Morin F, Westeel V, French Cooperative Thoracic Intergroup (IFCT). PMID: 42772370 [PubMed - as supplied by publisher]
	Development and internal validation of the OPERA-FE score incorporating area under the expiratory flow-volume curve for predicting postoperative complications after lung cancer surgery. Surg Oncol Yakisik C, Satici C, Azakli Yazici D, Saydam O, Cansever L, Tural S, Yazici I, Nedime Sokucu S. PMID: 42772110 [PubMed - as supplied by publisher]
	AI-Driven precision targeted therapy for EGFR-mutant non-small cell lung cancer: From therapeutic evolution and resistance mechanisms to intelligent decision systems. J Oncol Pharm Pract Wang F, Jiang H, Chen Y, Zhang Z, Wang Z, Liu W, Chi F. PMID: 42770465 [PubMed - as supplied by publisher]
	Circulating cytokines as potential dynamic biomarkers of PD-1 blockade response and prognosis in non-small cell lung cancer. Front Immunol Peng B, Li Y, Li S, Pan J, Qian W, Li Q. PMID: 42769976 [PubMed - indexed for MEDLINE]
	Artificial intelligence in non-small cell lung cancer: transforming diagnosis, treatment, and prognostic evaluation. Front Med (Lausanne) Zheng S, Lv C, Yao Z. PMID: 42769889 [PubMed]
	An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC. Front Immunol Li S, Du F, Leng C, Dou J, Shi J, Zhang Y, Lu F, Wang Q. PMID: 42769251 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162217

Page 1 of 8111



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy